Long-Term Administration of Beraprost Sodium for Pulmonary Arterial Hypertension Associated with Congenital Heart Disease
スポンサーリンク
概要
- 論文の詳細を見る
Pulmonary arterial hypertension (PAH) is often associated with congenital heart disease (CHD). Acute administration of beraprost reduces pulmonary vascular resistance in patients with idiopathic PAH and PAH associated with CHD; however, little is known about whether or not long-term treatment with oral beraprost benefits these patients. We report the case of a patient suffering from severe PAH associated with large patent ductus arteriosus (PDA), who was considered to be ineligible for PDA closure using a conventional treatment strategy. Eventually, long-term administration of oral beraprost ameliorated the degree of PAH and the patient subsequently underwent successful closure of the PDA.
論文 | ランダム
- 細石刃核の打面と作用面のなす角度の分析
- 生命分子の変化をつかさどるタンパク質触媒-酵素 : 触媒のしくみ,鏡像異性とのかかわりから物質合成まで(ヘッドライン:生体関連物質)
- 肥満と胸部X線所見
- Restructuring of Life and Outlook in the Pre-Retirement Period--Middle-Aged and Older Male Workers in Metropolitan Areas
- NbO及びNbN薄膜の電気抵抗の温度依存